XEOJO
LIVE

Serial Number

79226909

Owner

NOVARTIS AG

Filing Date

Nov 6, 2017

Add to watchlist:

No watchlists yet
View on USPTO

XEOJO Trademark

Serial Number: 79226909 • Registration: 5494798

XEOJO is a trademark filed by NOVARTIS AG on November 6, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 6, 2017

Registration Date

June 19, 2018

Published for Opposition

April 3, 2018

Cancellation Date

July 15, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

REFUSAL PROCESSED BY IB
Dec 12, 2021 RFNT
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 5, 2021 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 19, 2021 CRCV
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jul 31, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jul 31, 2021 DETH
NOTIFICATION PROCESSED BY IB
Aug 3, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 19, 2018 FICS
FINAL DISPOSITION PROCESSED
Jul 19, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 19, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2018 R.PR
PUBLISHED FOR OPPOSITION
Apr 3, 2018 PUBO
NOTICE OF PUBLICATION
Mar 14, 2018 NPUB
APPLICATION FILING RECEIPT MAILED
Mar 2, 2018 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2018 CNSA
ASSIGNED TO EXAMINER
Feb 26, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 21, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 15, 2018 REPR